# KINGSWAY Corp: financial statements, quarterly

KWY · NYSE · CIK 1072627 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kwy.md) · [Financials](/companies/kwy/financials.md) · [Filings](/companies/kwy/filings.md) · [Insiders](/companies/kwy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kwy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.8](/filings/0001437749-24-033642.md) | [25.9 d](/filings/0001437749-25-008039.md) | [26.2](/filings/0001437749-25-015475.md) | [26.4](/filings/0001437749-25-025403.md) | [27.1](/filings/0001437749-25-033593.md) | [29.6 d](/filings/0001437749-26-007961.md) | [28.3](/filings/0001437749-26-015567.md) | [30.9](/filings/0001437749-26-026247.md) | [37.2](/filings/0001437749-25-033593.md) | [38.6 d](/filings/0001437749-26-007961.md) | [39.0](/filings/0001437749-26-015567.md) | [39.4](/filings/0001437749-26-026247.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | [12.2](/filings/0001437749-26-015567.md) | [13.0](/filings/0001437749-26-026247.md) | not reported | not reported | [17.3](/filings/0001437749-26-015567.md) | [17.1](/filings/0001437749-26-026247.md) |
| Operating income | $m | [(0.2)](/filings/0001437749-24-033642.md) | [(0.1) d](/filings/0001437749-25-008039.md) | [0.8](/filings/0001437749-25-015475.md) | [0.1](/filings/0001437749-25-025403.md) | [(0.7)](/filings/0001437749-25-033593.md) | [1.8 d](/filings/0001437749-26-007961.md) | [(0.7)](/filings/0001437749-26-015567.md) | [(1.1)](/filings/0001437749-26-026247.md) | [(0.9)](/filings/0001437749-25-033593.md) | [0.3 d](/filings/0001437749-26-007961.md) | [0.5](/filings/0001437749-26-015567.md) | [(0.1)](/filings/0001437749-26-026247.md) |
| Interest expense | $m | [1.1](/filings/0001437749-24-033642.md) | [1.1 d](/filings/0001437749-24-006644.md) | [1.1](/filings/0001437749-24-015352.md) | [1.2](/filings/0001437749-24-024868.md) | [1.2](/filings/0001437749-24-033642.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001437749-24-033642.md) | [(2.7) d](/filings/0001437749-25-008039.md) | [0.1](/filings/0001437749-25-015475.md) | [0.1](/filings/0001437749-25-025403.md) | [0.0](/filings/0001437749-25-033593.md) | [(0.4) d](/filings/0001437749-26-007961.md) | [(0.3)](/filings/0001437749-26-015567.md) | [(0.1)](/filings/0001437749-26-026247.md) | [(2.1)](/filings/0001437749-25-033593.md) | [(1.3) d](/filings/0001437749-26-007961.md) | [(0.0)](/filings/0001437749-26-015567.md) | [0.2](/filings/0001437749-26-026247.md) |
| Net income | $m | [(0.7)](/filings/0001437749-24-033642.md) | [(1.5) d](/filings/0001437749-25-008039.md) | [(2.3)](/filings/0001437749-25-015475.md) | [(2.2)](/filings/0001437749-25-025403.md) | [(2.3)](/filings/0001437749-25-033593.md) | [(1.5) d](/filings/0001437749-26-007961.md) | [(3.1)](/filings/0001437749-26-015567.md) | [(3.2)](/filings/0001437749-26-026247.md) | [(2.4)](/filings/0001437749-25-033593.md) | [(1.6) d](/filings/0001437749-26-007961.md) | [(2.3)](/filings/0001437749-26-015567.md) | [0.2](/filings/0001437749-26-026247.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001437749-24-033642.md) | not reported | [(0.09)](/filings/0001437749-25-015475.md) | [(0.08)](/filings/0001437749-25-025403.md) | [(0.10)](/filings/0001437749-25-033593.md) | not reported | [(0.13)](/filings/0001437749-26-015567.md) | [(0.13)](/filings/0001437749-26-026247.md) | [(0.10)](/filings/0001437749-25-033593.md) | not reported | [(0.10)](/filings/0001437749-26-015567.md) | [(0.03)](/filings/0001437749-26-026247.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001437749-24-033642.md) | not reported | [(0.09)](/filings/0001437749-25-015475.md) | [(0.08)](/filings/0001437749-25-025403.md) | [(0.10)](/filings/0001437749-25-033593.md) | not reported | [(0.13)](/filings/0001437749-26-015567.md) | [(0.13)](/filings/0001437749-26-026247.md) | [(0.10)](/filings/0001437749-25-033593.md) | not reported | [(0.10)](/filings/0001437749-26-015567.md) | [(0.03)](/filings/0001437749-26-026247.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.2](/filings/0001437749-24-033642.md) | [9.1](/filings/0001437749-25-008039.md) | [12.1](/filings/0001437749-25-015475.md) | [9.6](/filings/0001437749-25-025403.md) | [6.5](/filings/0001437749-25-033593.md) | [5.5](/filings/0001437749-26-007961.md) | [6.4](/filings/0001437749-26-015567.md) | [12.1](/filings/0001437749-26-026247.md) | [9.3](/filings/0001437749-25-033593.md) | [8.3](/filings/0001437749-26-026247.md) | [7.3](/filings/0001437749-26-015567.md) | [7.4](/filings/0001437749-26-026247.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [76.5](/filings/0001437749-26-026247.md) | [78.1](/filings/0001437749-26-015567.md) | [79.2](/filings/0001437749-26-026247.md) |
| Total assets | $m | [198](/filings/0001437749-23-030641.md) | [198](/filings/0001437749-25-008039.md) | [198](/filings/0001437749-24-015352.md) | [192](/filings/0001437749-24-024868.md) | [191](/filings/0001437749-24-033642.md) | [187](/filings/0001437749-26-007961.md) | [192](/filings/0001437749-25-015475.md) | [208](/filings/0001437749-25-025403.md) | [235](/filings/0001437749-25-033593.md) | [231](/filings/0001437749-26-026247.md) | [232](/filings/0001437749-26-015567.md) | [228](/filings/0001437749-26-026247.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [83.6](/filings/0001437749-26-026247.md) | [85.0](/filings/0001437749-26-015567.md) | [90.7](/filings/0001437749-26-026247.md) |
| Total liabilities | $m | [170](/filings/0001437749-23-030641.md) | [173](/filings/0001437749-25-008039.md) | [177](/filings/0001437749-24-015352.md) | [175](/filings/0001437749-24-024868.md) | [171](/filings/0001437749-24-033642.md) | [168](/filings/0001437749-26-007961.md) | [171](/filings/0001437749-25-015475.md) | [172](/filings/0001437749-25-025403.md) | [199](/filings/0001437749-25-033593.md) | [197](/filings/0001437749-26-026247.md) | [200](/filings/0001437749-26-015567.md) | [195](/filings/0001437749-26-026247.md) |
| Long-term debt | $m | [40.9](/filings/0001437749-23-030641.md) | [44.4](/filings/0001437749-25-008039.md) | [47.1](/filings/0001437749-24-015352.md) | [47.3](/filings/0001437749-24-024868.md) | [58.5](/filings/0001437749-24-033642.md) | [57.5](/filings/0001437749-26-007961.md) | [59.5](/filings/0001437749-25-015475.md) | [58.3](/filings/0001437749-25-025403.md) | [70.7](/filings/0001437749-25-033593.md) | [59.0](/filings/0001437749-26-026247.md) | [55.3](/filings/0001437749-26-015567.md) | [44.5](/filings/0001437749-26-026247.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [11.7](/filings/0001437749-26-026247.md) | [15.8](/filings/0001437749-26-015567.md) | [22.8](/filings/0001437749-26-026247.md) |
| Shareholders' equity | $m | [31.6](/filings/0001437749-23-030641.md) | [27.7](/filings/0001437749-25-008039.md) | [23.6](/filings/0001437749-24-015352.md) | [20.7](/filings/0001437749-24-024868.md) | [9.9](/filings/0001437749-24-033642.md) | [8.4](/filings/0001437749-26-007961.md) | [5.5](/filings/0001437749-25-015475.md) | [17.4](/filings/0001437749-25-025403.md) | [16.6](/filings/0001437749-25-033593.md) | [15.2](/filings/0001437749-26-026247.md) | [13.2](/filings/0001437749-26-015567.md) | [12.8](/filings/0001437749-26-026247.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(835) d](/filings/0001437749-24-033642.md) | [(928) d](/filings/0001437749-25-008039.md) | [249](/filings/0001437749-25-015475.md) | [557 d](/filings/0001437749-25-025403.md) | [368 d](/filings/0001437749-25-033593.md) | [(107) d](/filings/0001437749-26-007961.md) | [(1,798)](/filings/0001437749-26-015567.md) | [337 d](/filings/0001437749-26-026247.md) | [1,468 d](/filings/0001437749-25-033593.md) | [(10.0) d](/filings/0001437749-26-007961.md) | [(8.0)](/filings/0001437749-26-015567.md) | [1,204 d](/filings/0001437749-26-026247.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | [63.0](/filings/0001437749-26-015567.md) | [(63.0) d](/filings/0001437749-26-026247.md) | [188 d](/filings/0001437749-25-033593.md) | not reported | [390](/filings/0001437749-26-015567.md) | [450 d](/filings/0001437749-26-026247.md) |
| Share repurchases | $k | [751 d](/filings/0001437749-24-033642.md) | [2,402 d](/filings/0001437749-25-008039.md) | [64.0](/filings/0001437749-25-015475.md) | [890 d](/filings/0001437749-25-025403.md) | [1,550 d](/filings/0001437749-25-033593.md) | [0.0 d](/filings/0001437749-26-007961.md) | [345](/filings/0001437749-26-015567.md) | [0.0 d](/filings/0001437749-26-026247.md) | [0.0 d](/filings/0001437749-25-033593.md) | [0.0 d](/filings/0001437749-26-007961.md) | [0.0](/filings/0001437749-26-015567.md) | [0.0 d](/filings/0001437749-26-026247.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.7](/filings/0001437749-23-030641.md) | [26.4](/filings/0001437749-24-015352.md) | [25.3](/filings/0001437749-24-024868.md) | [26.2](/filings/0001437749-24-033642.md) | [27.1](/filings/0001437749-25-015475.md) | [27.3](/filings/0001437749-25-025403.md) | [27.2](/filings/0001437749-25-033593.md) | [27.1](/filings/0001437749-26-015567.md) | [27.2](/filings/0001437749-26-026247.md) | [28.5](/filings/0001437749-25-033593.md) | [28.6](/filings/0001437749-26-015567.md) | [28.6](/filings/0001437749-26-026247.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,931,000 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026247.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.